BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35360663)

  • 1. Intra-Lot and Inter-Lot Variability in Ceftaroline Fosamil.
    Almeter PJ; Isaacs JT; Hunter AN; Henderson BS; Lodder RA
    Contact Context; 2021; 2021():. PubMed ID: 35360663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-Lot and Inter-Lot Variability in Cosyntropin.
    Almeter PJ; Isaacs JT; Hunter AN; Henderson BS; Lodder RA
    Contact Context; 2021; 2021():. PubMed ID: 35035309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrometric Results of Process Variations in Dacarbazine.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35035310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levothyroxine Variations by Process Analytical Technology.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35440917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTNIR Spectrometry of Micafungin Sodium Quality.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35360460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral Intra-Lot and Inter-Lot Variability in Carfilzomib.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Anwar H; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37008539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Process Control Issues with Pemetrexed.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35967958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrometric Analysis of Process Variations in Remifentanil.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 36187755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in Content of Piperacillin and Tazobactam Injection.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35506061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Content Uniformity in MMR Vaccine.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35360461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrometric Analysis of Dantrolene Sodium.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; McGuire C; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37424832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality Variations in Thyrotropin Alfa.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Samano-Garcia C; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37396298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium Vials.
    Isaacs JT; Almeter PJ; Hunter AN; Lyman TA; Zapata SP; Henderson BS; Larkin SA; Long LM; Bossle MN; Bhaktawara SA; Warren MF; Lozier AM; Melson JD; Fraley SR; Relucio EHL; Felix MA; Reynolds JW; Naseman RW; Platt TL; Lodder RA
    Contact Context; 2024; 2024():. PubMed ID: 38774605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and determination of related substances of ceftaroline fosamil in medicinal product by high performance liquid chromatography with diode array detection and tandem mass spectrometry.
    Karpiuk I; Michalska K; Bus K; Kiljan M; Tyski S
    J Pharm Biomed Anal; 2017 Oct; 145():651-660. PubMed ID: 28800526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in Content of Hydrocortisone Sodium Succinate.
    Felix M; Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37600448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects.
    Riccobene TA; Su SF; Rank D
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1496-504. PubMed ID: 23295928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
    Lodise TP; Low DE
    Drugs; 2012 Jul; 72(11):1473-93. PubMed ID: 22779432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    File TM; Low DE; Eckburg PB; Talbot GH; Friedland HD; Lee J; Llorens L; Critchley IA; Thye DA;
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii19-32. PubMed ID: 21482566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.
    Frampton JE
    Drugs; 2013 Jul; 73(10):1067-94. PubMed ID: 23801418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    Low DE; File TM; Eckburg PB; Talbot GH; David Friedland H; Lee J; Llorens L; Critchley IA; Thye DA;
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii33-44. PubMed ID: 21482568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.